arrow
H

Henryk Dreger

Charité - Universitätsmedizin Berlin
H指数:36
被引数:5,190

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Timely hospital discharge in TAVI patients: towards a patient-centered care pathway

TAVI患者的及时出院:迈向以患者为中心的护理路径

2026-05-280
OAAI
Screening for amyloidosis before aortic valve elective replacement: results from the SAVER study

主动脉瓣择期置换术前淀粉样变性筛查:SAVER研究的结果

2026-04-220
PRE
Early safety and efficacy of intra-annular versus supra-annular self-expanding transcatheter heart valves

经导管心脏瓣膜的早期安全性和有效性:瓣环内与瓣环上自膨胀瓣膜的比较

2026-04-080
OAAI
Left Ventricular Global Longitudinal Strain Predicts Pacemaker-Associated Cardiomyopathy with Substantial LVEF Deterioration: Results from a Single-Center Cohort Study in Germany

左心室整体纵向应变预测起搏器相关心肌病伴显著LVEF恶化:来自德国一项单中心队列研究的结果

2026-04-060
OAAI
Frequency and Outcomes of Acute Hemodynamic Instability Following Transcatheter Tricuspid Valve Replacement

经导管三尖瓣置换术后急性血流动力学不稳定的频率和结局

2026-03-230
OAAI
Association of high-risk CT coronary artery plaque features with major adverse cardiovascular events: a prespecified secondary analysis of the DISCHARGE trial

高风险CT冠状动脉斑块特征与主要不良心血管事件的相关性:DISCHARGE试验的预先设定的次要分析

2026-02-130
OAAI
GLIDE Score is associated with procedural success in patients undergoing direct transcatheter tricuspid valve annuloplasty

GLIDE Score与接受直接经导管三尖瓣环成形术患者的操作成功率相关。

2025-12-010
PRE
TCT-1221 ReTAVI Registry: Early Outcomes of Redo-TAVI with SAPIEN Platform in a Real-World Prospective Cohort

TCT-1221 ReTAVI 注册研究:真实世界前瞻性队列中采用 SAPIEN 平台进行二次 TAVI 的早期结果

JACC
IF0
2025-10-220
PRE